Sarda Proteins Ltd — Board Meeting, 29-11-2025: Board Meeting
29-11-2025 | 10:14 pm
29-11-2025 | 10:14 pm
Sarda Proteins' board approved its Q2 & H1 FY26 financial results. For the half-year, revenue was ₹15.26 Cr with a loss of ₹0.09 Cr. The quarter saw revenue of ₹4.30 Cr and a profit of ₹0.40 Cr, with Q2 EPS at ₹2.34.
No comments yet. Be the first to comment!
